1. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction;Lancet,1986
2. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction;Lancet,1990
3. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of mortality and major morbidity results from all randomized trials of more than 1000 patients;Lancet,1994
4. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2;Lancet,1988
5. ISIS-3: a randomised comparison of streptokinase vs. tissue plasminogen activator vs. anistreplase and of aspirin and heparin vs. heparin alone among 41,299 cases of suspected acute myocardial infarction;Lancet,1992